Hi I have a question about the drug Remdesivir, and more precisely about its use. My mom was in the hospital 5 days in November 2021. She had pneumonia - occupied 40% against the background of covid. She was given the drug Remdesivir - however, from what I learned, this drug did more harm than it worked, and due to the fact that it was treated as an experiment (knowledge for November 2021), she should sign a consent for it and be informed about it? is this true?
* required field
* required field
Suggested Products
Space for your product
Olga Sierpniowska Pharmacist
3 years ago
The drug Veklury with remdesivir (to the best of my knowledge only this product was distributed by RARS to hospitals), was authorized for the treatment of COVID-19 in the European Union in July 2020. Below is a link to the recommendation for such a decision issued in June 2020: https://www.ema.europa.eu/en/news/first-covid-19-treatment-recommended-eu-authorisation Therefore, in my opinion, the use of this drug in November 2021 in the treatment of COVID-19 will not meet the conditions for a medical experiment requiring additional patient consent for administration. This does not detract from the patient's rights regarding the right to information m.in "about the state of health, diagnosis, proposed and possible diagnostic and therapeutic methods, foreseeable consequences of their use or omission, results of treatment and prognosis". At the same time, general consents for treatment should be taken from the patient at the stage of admission to the hospital. I enclose additional information: https://www.gdziepolek.pl/kategorie/leki-na-covid-19